ERA-Net (MOH): European Joint Programme for Rare Diseases (EJP RD): Natural History Studies addressing unmet needs in Rare Diseases (RD) (Pre-proposal)

The program supports consortia of 4-6  (8 in some cases) PIs from at least 4 different participating countries (see in the call).

Research proposals should cover at least one of the following areas:

• Estimation of disease prevalence;
• Identification of biomarkers/companions for the diagnosis/prognosis of a RD;
• Identification of biomarkers/indicators/predictors of a RD or group of disorders onset/progression;
• Identification of relevant endpoints for future studies that include potential biomarkers, querying patient-reported outcomes (PROs) and quality-of-life measures;
• Identification of biomarkers/variables for therapeutic approaches (pharmacology, drug repurposing, gene therapy, RNA therapy, cell therapy, medical devices…).

Funding for the Israeli partner: €140K over 3 years.

* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1588).

https://www.ejprarediseases.org/joint-transnational-call-2023/